OpenURL Connection Search

Select item for more details and to access through your institution.

Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions.
Published in:
Cytopathology, 2008, v. 19, n. 4, p. 205, doi. 10.1111/j.1365-2303.2007.00468.x
By:
- Metzgeroth, G.;
- Kuhn, C.;
- Schultheis, B.;
- Hehlmann, R.;
- Hastka, J.
Publication type:
Article
Pseudomembranous tracheobronchial aspergillosis: a rare manifestation of invasive aspergillosis in a non-neutropenic patient with Hodgkin's disease.
Published in:
Mycoses, 2003, v. 46, n. 1/2, p. 51, doi. 10.1046/j.1439-0507.2003.00812.x
By:
- Buchheidt, D.;
- Weiss, A.;
- Reiter, S.;
- Hartung, G.;
- Hehlmann, R.
Publication type:
Article
MURINE AND HUMAN MELANOMAS CONTAINING A HIGH MOLECULAR WEIGHT RNA ASSOCIATED WITH AN RNA- INSTRUCTED DNA POLYMERASE.
Published in:
International Journal of Dermatology, 1978, v. 17, n. 2, p. 114, doi. 10.1111/j.1365-4362.1978.tb06120.x
By:
- Hehlmann, R.;
- Balda, B.-R.;
- Spiegelman, S.
Publication type:
Article
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML.
Published in:
Bone Marrow Transplantation, 1998, v. 21, n. 10, p. 1029, doi. 10.1038/sj.bmt.1701229
By:
- Fischer, T.;
- Neubauer, A.;
- Mohm, J.;
- Huhn, D.;
- Busemann, C.;
- Link, H.;
- Arseniev, L.;
- Bussing, B.;
- Novotny, J.;
- Ganser, A.;
- Duyster, J.;
- Bunjes, D.;
- Kreiter, S.;
- Aulitzky, W.;
- Hehlmann, R.;
- Huber, W.
Publication type:
Article
Essential thrombocythemia. Clinical characteristics and course of 61 cases.
Published in:
1988
By:
- Hehlmann, R.;
- Jahn, M.;
- Baumann, B.;
- Köpcke, W.;
- Köpcke, W
Publication type:
journal article
Antigens and circulating immune complexes related to the primate retroviral glycoprotein SiSVgp70. Indicators of early mortality in human acute leukemias and chronic myelogenous leukemias in blast crisis.
Published in:
1984
By:
- Hehlmann, Rüdiger;
- Erfle, Volker;
- Schetters, Hartmut;
- Luz, Arne;
- Rohmer, Heike;
- Schreiber, Martin A.;
- Pralle, Hans;
- Essers, Ursula;
- Weber, Walter;
- Hehlmann, R;
- Erfle, V;
- Schetters, H;
- Luz, A;
- Rohmer, H;
- Schreiber, M A;
- Pralle, H;
- Essers, U;
- Weber, W
Publication type:
journal article
Intestinal-type adenocarcinoma situated in the nasopharynx.
Published in:
Cytopathology, 2007, v. 18, n. 1, p. 59, doi. 10.1111/j.1365-2303.2006.00357.x
By:
- Metzgeroth, G.;
- Back, W.;
- Schultheis, B.;
- Maywald, O.;
- Kuhn, C.;
- Hehlmann, R.;
- Hastka, J.
Publication type:
Article
Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization.
Published in:
Leukemia (08876924), 2002, v. 16, n. 12, p. 2395
By:
- Müller, M C;
- Merx, K;
- Weiβer, A;
- Kreil, S;
- Lahaye, T;
- Hehlmann, R;
- Hochhaus, A
Publication type:
Article
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy .
Published in:
Leukemia (08876924), 2002, v. 16, n. 11, p. 2190, doi. 10.1038/sj.leu.2402741
By:
- Hochhaus, A.;
- Kreil, S.;
- Corbin, A.S.;
- La Rosee, P.;
- Cross, N.C.P.;
- Berger, U.;
- Gschaidmeier, H.;
- Hehlmann, R.
Publication type:
Article
Alterations of the cyclin D1/pRb/p16[supINK4A] pathway in multiple myeloma.
Published in:
Leukemia (08876924), 2002, v. 16, n. 9, p. 1844
By:
- Kramer, A.;
- Schultheis, B.;
- Bermann, J.;
- Willer, A.;
- Hegenbart, U.;
- Ho, A.D.;
- Goldschmidt, H.;
- Hehlmann, R.
Publication type:
Article
Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α.
Published in:
Leukemia (08876924), 2002, v. 16, n. 9, p. 1579, doi. 10.1038/sj.leu.2402680
By:
- Merx, K.;
- Muller, M.C.;
- Kreil, S.;
- Lahaye, T.;
- Paschka, P.;
- Schoch, C.;
- Weisser, A.;
- Kuhn, C.;
- Berger, U.;
- Gschaidmeier, H.;
- Hehlmann, R.;
- Hochhaus, A.
Publication type:
Article
Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT).
Published in:
Leukemia (08876924), 2002, v. 16, n. 7, p. 1220, doi. 10.1038/sj.leu.2402565
By:
- Fischer, T.;
- Reifenrath, C.;
- Hess, G.R.;
- Corsetti, M.T.;
- Kreil, S.;
- Beck, J.;
- Meinhardt, P.;
- Beltrami, G.;
- Schuch, B.;
- Gschaidmeier, H.;
- Hehlmann, R.;
- Hochhaus, A.;
- Carella, A.;
- Huber, C.
Publication type:
Article
Comparison of chromosome banding analysis, interphase-and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.
Published in:
Leukemia (08876924), 2002, v. 16, n. 1, p. 53, doi. 10.1038/sj.leu.2402329
By:
- Schoch, C.;
- Schnittger, S.;
- Bursch, S.;
- Gerstner, D.;
- Hochhaus, A.;
- Berger, U.;
- Hehlmann, R.;
- Hiddemann, W.;
- Haferlach, T.
Publication type:
Article
Reply to Sanz et al.
Published in:
Leukemia (08876924), 2001, v. 15, n. 12, p. 2000
By:
- Lengfelder, E;
- Hehlmann, R;
- Büchner, T
Publication type:
Article
Response to Sanz et al.
Published in:
Leukemia (08876924), 2001, v. 15, n. 12, p. 2002
By:
- Lengfelder, E;
- Hehlmann, R;
- Büchner, T
Publication type:
Article
Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemia.
Published in:
2001
By:
- Krämer, A;
- Löffler, H;
- Bergmann, J;
- Hochhaus, A;
- Hehlmann, R
Publication type:
journal article
Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes.
Published in:
2000
By:
- Saussele, S;
- Weisser, A;
- Müller, M C;
- Emgi, M;
- La Rosée, P;
- Paschka, P;
- Kuhn, C;
- Willer, A;
- Hehlmann, R;
- Hochhaus, A
Publication type:
journal article
Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probes.
Published in:
Leukemia (08876924), 2000, v. 14, n. 11, p. 2006
By:
- Saußele, S;
- Weißer, A;
- Müller, M C;
- Emig, M;
- Rosée, P La;
- Paschka, P;
- Kuhn, C;
- Willer, A;
- Hehlmann, R;
- Hochhaus, A
Publication type:
Article
Trial of IFN or STI571 before proceeding to allografting for CML?
Published in:
2000
By:
- Hehlmann, R
Publication type:
journal article
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group.
Published in:
2000
By:
- Lengfelder, E.;
- Reichert, A.;
- Schoch, C.;
- Haase, D.;
- Haferlach, T.;
- Löffler, H.;
- Staib, P.;
- Heyll, A.;
- Seifarth, W.;
- Saussele, S.;
- Fonatsch, C.;
- Gassmann, W.;
- Ludwig, W.-D.;
- Hochhaus, A.;
- Beelen, D.;
- Aul, C.;
- Sauerland, M.-C.;
- Heinecke, A.;
- Hehlmann, R.;
- Wörmann, B.
Publication type:
journal article
Detection and quantification of residual disease in chronic myelogenous leukemia.
Published in:
Leukemia (08876924), 2000, v. 14, n. 6, p. 998, doi. 10.1038/sj.leu.2401811
By:
- Hochhaus, A;
- Weisser, A;
- Rosée, P La;
- Emig, M;
- Müller, M C;
- Saußele, S;
- Reiter, A;
- Kuhn, C;
- Berger, U;
- Hehlmann, R;
- Cross, N C P
Publication type:
Article
Analysis of p73 and p53 gene deletions in multiple myeloma.
Published in:
1999
By:
- Schultheis, B;
- Krämer, A;
- Willer, A;
- Hegenbart, U;
- Goldschmidt, H;
- Hehlmann, R
Publication type:
journal article
Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.
Published in:
1999
By:
- Emig, M;
- Saußele, S;
- Wittor, H;
- Weißer, A;
- Reiter, A;
- Willer, A;
- Berger, U;
- Hehlmann, R;
- Cross, N C P;
- Hochhaus, A;
- Saussele, S;
- Weisser, A;
- Cross, N C
Publication type:
journal article
Impact of human endogenous retroviral elements on cellular genes: strategy for isolation of LTR-driven chimeric transcripts.
Published in:
1999
By:
- Seifarth, W.;
- Krieg-Schneider, F.;
- Skladny, H.;
- Marachelian, A.;
- Germaier, H.;
- Hehlmann, R.;
- Leib-Mösch, C.;
- Leib-Mösch, C
Publication type:
journal article
Comparative research in leukemia and related diseases. An introduction to a scientific approach.
Published in:
Leukemia (08876924), 1999, v. 13, p. S19, doi. 10.1038/sj.leu.2401289
By:
- Hehlmann, R.;
- Essex, M.
Publication type:
Article
Does long-term culture favor normal clonogenic cells from interferon-treated patients with chronic myelogenous leukemia?
Published in:
1999
By:
- Pasternak, G.;
- Schultheis, B.;
- Heissig, B.;
- Hömer, S.;
- Sick, C.;
- Hehlmann, R.;
- Hörner, S
Publication type:
journal article
PREFACE.
Published in:
Leukemia (08876924), 1999, v. 13, p. S1
By:
- Hehlmann, R.
Publication type:
Article
Cyclin A1 is predominantly expressed in hematological malignancies with myeloid differentiation.
Published in:
1998
By:
- Krämer, A;
- Hochhaus, A;
- Saußele, S;
- Reichert, A;
- Willer, A;
- Hehlmann, R;
- Saussele, S
Publication type:
journal article
Expression of interferon regulatory factor (IRF) genes and response to interferon-alpha in chronic myeloid leukaemia.
Published in:
1997
By:
- Hochhaus, A;
- Yan, X H;
- Willer, A;
- Hehlmann, R;
- Gordon, M Y;
- Goldman, J M;
- Melo, J V
Publication type:
journal article
RANDOMIZED STUDIES WITH INTERFERON IN CHRONIC MYELOGENOUS LEUKEMIA (CML) AND COMPARATIVE MOLECULAR ASPECTS.
Published in:
Leukemia (08876924), 1997, v. 11, p. 506
By:
- R., Hehlmann;
- A., Wilier;
- H., Heimpel;
- J., Hasford;
- H. J., Kolb;
- H., Pralle;
- D. K., Hossfeld;
- W., Queißer;
- H., Löffler;
- A., Hochhaus;
- A., Tobler;
- E., Lengfelder;
- U., Berger;
- C., Leib-Mösch
Publication type:
Article
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.
Published in:
1998
By:
- Hasford, Joerg;
- Pfirrmann, Markus;
- Hehlmann, Rüdiger;
- Allan, Norman C.;
- Baccarani, Michele;
- Kluin-Nelemans, Johanna C.;
- Alimena, Guiliana;
- Steegmann, Juan Luis;
- Ansari, Hassan;
- Hasford, J;
- Pfirrmann, M;
- Hehlmann, R;
- Allan, N C;
- Baccarani, M;
- Kluin-Nelemans, J C;
- Alimena, G;
- Steegmann, J L;
- Ansari, H
Publication type:
journal article
BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR).
Published in:
Investigational New Drugs, 2005, v. 23, n. 4, p. 363, doi. 10.1007/s10637-005-1445-z
By:
- R.-D. Hofheinz;
- C. Porta;
- G. Hartung;
- A. Santoro;
- A.-R. Hanauske;
- K. Kutz;
- A. Stern;
- P. Barbieri;
- E. Verdi;
- R. Hehlmann;
- A. Hochhaus
Publication type:
Article
Multilobated nuclei in Waldenström’ macroglobulinaemia.
Published in:
European Journal of Haematology, 2003, v. 71, n. 4, p. 307, doi. 10.1034/j.1600-0609.2003.00118.x
By:
- Metzgeroth, G.;
- Sick, Ch.;
- Maywald, O.;
- Schatz, M.;
- Kuhn, Ch.;
- Hehlmann, R.;
- Hastka, J.
Publication type:
Article
Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors.
Published in:
2012
By:
- Saußele, S;
- Hehlmann, R;
- Gratwohl, A;
- Hochhaus, A
Publication type:
Letter
Imatinib and beyond—the new CML study IV: A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia.
Published in:
Annals of Hematology, 2004, v. 83, n. 4, p. 258, doi. 10.1007/s00277-003-0807-x
By:
- Berger, U.;
- Engelich, G.;
- Reiter, A.;
- Hochhaus, A.;
- Hehlmann, R.
Publication type:
Article
Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection—case report and review of the literature.
Published in:
Annals of Hematology, 2004, v. 83, n. 3, p. 189
By:
- Maywald, O.;
- Buchheidt, D.;
- Bergmann, J.;
- Schoch, C.;
- Ludwig, W.-D.;
- Reiter, A.;
- Hastka, J.;
- Lengfelder, E.;
- Hehlmann, R.
Publication type:
Article
Auer rod-like inclusions in multiple myeloma.
Published in:
Annals of Hematology, 2003, v. 82, n. 1, p. 57, doi. 10.1007/s00277-002-0574-0
By:
- Metzgeroth, G.;
- Back, W.;
- Maywald, O.;
- Schatz, M.;
- Willer, A.;
- Hehlmann, R.;
- Hastka, J.
Publication type:
Article
Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.
Published in:
Annals of Hematology, 2002, v. 81, n. 8, p. 467, doi. 10.1007/s00277-002-0505-0
By:
- Leo, E.;
- Krämer, A.;
- Hochhaus, A.;
- Krasniqi, F.;
- Hehlmann, R.;
- Ho, A.
Publication type:
Article
Predominantly BCR-ABL negative myeloid precursors in interferon-α treated chronic myelogenous leukemia: a follow-up study of peripheral blood colony-forming cells with fluorescence in situ hybridization.
Published in:
Annals of Hematology, 2001, v. 80, n. 1, p. 9, doi. 10.1007/s002770000237
By:
- Sick, C.;
- Schultheis, B.;
- Pasternak, G.;
- Kottke, I.;
- Hörner, S.;
- Heissig, B.;
- Hehlmann, R.
Publication type:
Article
Current trends in the management of chronic myelogenous leukemia.
Published in:
Annals of Hematology, 2000, v. 79, n. 7, p. 345, doi. 10.1007/s002770000167
By:
- Hehlmann, R.;
- Hochhaus, A.;
- Berger, U.;
- Reiter, A.
Publication type:
Article
Interferon alpha in the treatment of polycythemia vera.
Published in:
2000
By:
- Lengfelder, E;
- Berger, U;
- Hehlmann, R
Publication type:
journal article
Interferon α in the treatment of polycythemia vera.
Published in:
Annals of Hematology, 2000, v. 79, n. 3, p. 103, doi. 10.1007/s002770050563
By:
- Lengfelder, E.;
- Berger, U.;
- Hehlmann, R.
Publication type:
Article
Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia.
Published in:
Leukemia (08876924), 2015, v. 29, n. 6, p. 1331, doi. 10.1038/leu.2015.45
By:
- Burchert, A;
- Saussele, S;
- Eigendorff, E;
- Müller, M C;
- Sohlbach, K;
- Inselmann, S;
- Schütz, C;
- Metzelder, S K;
- Ziermann, J;
- Kostrewa, P;
- Hoffmann, J;
- Hehlmann, R;
- Neubauer, A;
- Hochhaus, A
Publication type:
Article
Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).
Published in:
Leukemia (08876924), 2015, v. 29, n. 1, p. 20, doi. 10.1038/leu.2014.250
By:
- Barosi, G;
- Tefferi, A;
- Besses, C;
- Birgegard, G;
- Cervantes, F;
- Finazzi, G;
- Gisslinger, H;
- Griesshammer, M;
- Harrison, C;
- Hehlmann, R;
- Hermouet, S;
- Kiladjian, J-J;
- Kröger, N;
- Mesa, R;
- Mc Mullin, M F;
- Pardanani, A;
- Passamonti, F;
- Samuelsson, J;
- Vannucchi, A M;
- Reiter, A
Publication type:
Article
Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib.
Published in:
Leukemia (08876924), 2014, v. 28, n. 10, p. 1988, doi. 10.1038/leu.2014.153
By:
- Hanfstein, B;
- Shlyakhto, V;
- Lauseker, M;
- Hehlmann, R;
- Saussele, S;
- Dietz, C;
- Erben, P;
- Fabarius, A;
- Proetel, U;
- Schnittger, S;
- Krause, S W;
- Schubert, J;
- Einsele, H;
- Hänel, M;
- Dengler, J;
- Falge, C;
- Kanz, L;
- Neubauer, A;
- Kneba, M;
- Stegelmann, F
Publication type:
Article
MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure.
Published in:
Leukemia (08876924), 2014, v. 28, n. 7, p. 1478, doi. 10.1038/leu.2014.6
By:
- Agrawal, M;
- Hanfstein, B;
- Erben, P;
- Wolf, D;
- Ernst, T;
- Fabarius, A;
- Saussele, S;
- Purkayastha, D;
- Woodman, R C;
- Hofmann, W-K;
- Hehlmann, R;
- Hochhaus, A;
- Müller, M C
Publication type:
Article
Re-emergence of interferon-α in the treatment of chronic myeloid leukemia.
Published in:
2013
By:
- Talpaz, M;
- Hehlmann, R;
- Quintás-Cardama, A;
- Mercer, J;
- Cortes, J
Publication type:
journal article
Re-emergence of interferon-α in the treatment of chronic myeloid leukemia.
Published in:
Leukemia (08876924), 2013, v. 27, n. 4, p. 803, doi. 10.1038/leu.2012.313
By:
- Talpaz, M;
- Hehlmann, R;
- Quintás-Cardama, A;
- Mercer, J;
- Cortes, J
Publication type:
Article
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
Published in:
2012
By:
- Hanfstein B;
- Müller MC;
- Hehlmann R;
- Erben P;
- Lauseker M;
- Fabarius A;
- Schnittger S;
- Haferlach C;
- Göhring G;
- Proetel U;
- Kolb HJ;
- Krause SW;
- Hofmann WK;
- Schubert J;
- Einsele H;
- Dengler J;
- Hänel M;
- Falge C;
- Kanz L;
- Neubauer A
Publication type:
Journal Article
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).
Published in:
Leukemia (08876924), 2012, v. 26, n. 9, p. 2096, doi. 10.1038/leu.2012.85
By:
- Hanfstein, B;
- Müller, M C;
- Hehlmann, R;
- Erben, P;
- Lauseker, M;
- Fabarius, A;
- Schnittger, S;
- Haferlach, C;
- Göhring, G;
- Proetel, U;
- Kolb, H-J;
- Krause, S W;
- Hofmann, W-K;
- Schubert, J;
- Einsele, H;
- Dengler, J;
- Hänel, M;
- Falge, C;
- Kanz, L;
- Neubauer, A
Publication type:
Article

Found: 85